Skip to content

Glycemic Response Testing

Glycaemic Response Testing

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01536860
Enrollment
12
Registered
2012-02-22
Start date
2012-02-29
Completion date
2012-03-31
Last updated
2013-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glycemic Index, Glycemic Response

Brief summary

The purpose of this study is to assess whether added food ingredient(s) affect glycemic responses to a liquid meal tolerance test (LMTT).

Interventions

OTHERDietary Intervention

300 ml of liquid food product

Sponsors

Reading Scientific Services Ltd.
CollaboratorINDUSTRY
Mondelēz International, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female (not less than 40% males or females * Non-smoker * Aged 18 to 55 years * Have a body mass index between 18.5 to 29.99 kg/m2 * Healthy, non-diabetic, no gastric bypass surgery * Not allergic to mustard, dairy or soy * Having a fasting plasma glucose (finger stick) \<100 mg/dl (\<5.5 mmol/L) * Willing and able to provide written informed consent

Design outcomes

Primary

MeasureTime frameDescription
Glycemic Response Measured as the Positive Incremental Area Under the Time-concentration Curve(iAUC) Calculated From Individual Glucose Measurements Upon Consumption of Control and Experimental Test Food Products0-120 minutesThe individual glucose measurements were collected at baseline (prior to consumption of each test food product and 15, 30, 45, 60, 90 and 120 minutes following the initiation of consumption of each test food product. The positive incremental area under the time-concentration curve (iAUC) was then calculated for the entire 120 minutes after consumption of each test food product. The results show the differential treatment-related effect on the time-concentration curve (iAUC) for the entire 120 minutes post consumption of each test food product.

Countries

United Kingdom

Participant flow

Recruitment details

A total of 11 subjects completed the study. The study was conducted at one clinical research site and study started February, 2012 and was completed in March 2012.

Pre-assignment details

This was a randomized double blind cross-over study. There was a wash out period of 3 or more days between interventions.

Participants by arm

ArmCount
Entire Study Population
Includes groups randomized to receive Control Test Drink first, Exp Test Drink 1 first and Exp Test Drink 2 first.
12
Total12

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Washout Period (3 Days)Lost to Follow-up100

Baseline characteristics

CharacteristicEntire Study Population
Age, Categorical
<=18 years
1 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
11 Participants
Sex: Female, Male
Female
7 Participants
Sex: Female, Male
Male
5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 120 / 120 / 11
serious
Total, serious adverse events
0 / 120 / 120 / 11

Outcome results

Primary

Glycemic Response Measured as the Positive Incremental Area Under the Time-concentration Curve(iAUC) Calculated From Individual Glucose Measurements Upon Consumption of Control and Experimental Test Food Products

The individual glucose measurements were collected at baseline (prior to consumption of each test food product and 15, 30, 45, 60, 90 and 120 minutes following the initiation of consumption of each test food product. The positive incremental area under the time-concentration curve (iAUC) was then calculated for the entire 120 minutes after consumption of each test food product. The results show the differential treatment-related effect on the time-concentration curve (iAUC) for the entire 120 minutes post consumption of each test food product.

Time frame: 0-120 minutes

ArmMeasureValue (MEAN)Dispersion
Control Test DrinkGlycemic Response Measured as the Positive Incremental Area Under the Time-concentration Curve(iAUC) Calculated From Individual Glucose Measurements Upon Consumption of Control and Experimental Test Food Products100 mmol*min/LStandard Error 17
Experimental Test Drink 1Glycemic Response Measured as the Positive Incremental Area Under the Time-concentration Curve(iAUC) Calculated From Individual Glucose Measurements Upon Consumption of Control and Experimental Test Food Products68 mmol*min/LStandard Error 10
Experimental Test Drink 2Glycemic Response Measured as the Positive Incremental Area Under the Time-concentration Curve(iAUC) Calculated From Individual Glucose Measurements Upon Consumption of Control and Experimental Test Food Products73 mmol*min/LStandard Error 13

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026